Nebla, Arnulfo S.
HRN: 17-40-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2024
CIPROFLOXACIN 500MG (TAB)
08/13/2024
08/19/2024
ORAL
500mg
BID
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes